Judges Scientific (JDG) AI Stock Analysis

• Market Cap: £525.16M
• Dividend Yield: 1.24%
• Average Volume (3M): 13.12K
• Price to Earnings (P/E): 50.4
• Beta (1Y): 0.38
• Revenue Growth: -1.84%
• EPS Growth: 9.56%
• Country: UK
• Employees: 767
• Sector: Technology
• Sector Strength: 84
• Industry: Hardware, Equipment & Parts
• EPS (TTM): 1.57
• Shares Outstanding: 6,647,542
• 10 Day Avg. Volume: 8,538
• 30 Day Avg. Volume: 13,121
• PEG Ratio: 0.54
• Price to Book (P/B): 5.32
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 30.60
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £9,850.00
• Price Target Upside: 26.28% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 70 Neutral
• Price Target: 8,796.00p ▲(12.77%Upside)

Judges Scientific's overall score is driven by strong financial performance and positive corporate events. Technical analysis shows moderate potential, but valuation concerns due to a high P/E ratio temper enthusiasm. Continued positive corporate actions and financial management are key strengths.

Positive Factors

Financial Performance

Judges' FY24 Results are in line with guidance and with JEFe, with the improvement in cash flow being the highlight.

Management Strength

There remains a strong management team in place.

Track Record

Judges has an impressive track record of value creation, margin expansion, and organic growth.

Negative Factors

Leadership Changes

It is disappointing to see Mark Lavelle depart, as he is very well-regarded and brought valuable experience and knowledge to Judges.

US Market Risks

There is little conviction around the growth/margin recovery needed to drive rerating of the shares, especially with downside risk in the US from research funding cuts and delayed customer investment decisions.

US Sales Risk

25% of sales in the US, with academia accounting for half, face downside risk from wider demand destruction.

Judges Scientific Business Overview & Revenue Model

Company Description

Judges Scientific plc designs, manufactures, and sells scientific instruments. The company operates through two segments, Materials Sciences and Vacuum. It offers engineering teaching and research equipment for universities, colleges, schools, and research centers; and research and development systems for food, beverage, dairy, edible oil, and pharmaceutical industries. The company also provides LED illumination systems for bioscience and clinical microscopy; tensile testing, motion control, and specimen cooling for microscopy applications; automated measurement systems for a range of fibers; edge-welded metal bellows; and fire testing instruments, such as cone calorimeters, large scale calorimeters, NBS smoke chambers and oxygen index test, and related fire testing instruments. In addition, it offers equipment and software used for the computer-controlled testing of soils and rocks; film deposition systems; physical and chemical vapour deposition instruments; open flow cryocoolers for the X-ray diffraction market and crycoolers for cooling applications, such as radio astronomy; test equipment for the characterization of optical fibers; scientific instruments primarily used for electron microscopy sample preparation; scientific equipment used by electrophysiology and imaging researchers; and gas purifiers for metal analysis. Further, the company provides specialized calorimeters used for chemical and battery industries; sample heating and manipulation products for use in vacuum markets for materials research and production; and sheet metalwork services, including components and casting, fabrication, bespoke engineering solutions, as well as laser cutting and CNC machining services. The company operates in the United Kingdom, rest of Europe, North America, China, and internationally. Judges Scientific plc was incorporated in 2002 and is based in London, the United Kingdom.

How the Company Makes Money

Judges Scientific makes money by acquiring and managing a portfolio of scientific instrument companies. The company's revenue model is centered around the sales of high-value, precision scientific instruments manufactured by its subsidiaries. These instruments are used by research institutions, laboratories, and industrial companies. Revenue is generated through the direct sale of these products, as well as through ongoing service and maintenance contracts. The company benefits from a diversified product range and customer base, reducing dependency on any single revenue stream. Additionally, it may engage in strategic partnerships to enhance its market reach and technological capabilities, although specific partnerships are not detailed.

Judges Scientific Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
135.60M	136.10M	113.21M	91.29M	79.86M	82.50M
	Gross Profit
65.40M	93.60M	21.01M	15.34M	10.02M	14.35M
	EBIT
27.00M	21.60M	21.13M	15.25M	9.96M	14.35M
	EBITDA
39.30M	35.60M	29.00M	20.33M	15.17M	18.54M
	Net Income Common Stockholders
14.90M	9.50M	12.50M	12.68M	8.22M	11.38M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
15.73M	13.70M	20.83M	18.41M	15.52M	14.12M
	Total Assets
65.73M	183.50M	185.79M	88.98M	82.03M	70.61M
	Total Debt
15.03M	65.30M	59.95M	21.32M	26.37M	18.90M
	Net Debt
-701.00K	51.60M	39.12M	2.91M	10.85M	4.77M
	Total Liabilities
34.52M	100.90M	131.33M	45.58M	48.98M	41.92M
	Stockholders Equity
30.64M	82.40M	54.24M	42.78M	32.19M	27.87M
Cash Flow		Free Cash Flow
15.20M	20.60M	12.33M	13.44M	10.53M	15.28M
	Operating Cash Flow
21.30M	26.50M	20.22M	16.89M	11.79M	16.58M
	Investing Cash Flow
-11.70M	-25.90M	-51.11M	-5.21M	-12.67M	-1.37M
	Financing Cash Flow
-17.40M	-7.60M	33.21M	-8.81M	2.34M	-16.76M

Judges Scientific Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 7800.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:JDG, the sentiment is Positive. The current price of 7800 is below the 20-day moving average (MA) of 8054.00, above the 50-day MA of 7294.80, and below the 200-day MA of 8331.79, indicating a neutral trend. The MACD of 187.63 indicates Positive momentum. The RSI at 57.28 is Neutral, neither overbought nor oversold. The STOCH value of 52.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:JDG.

Judges Scientific Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SOLI	78 Outperform	£110.49M	20.72	8.61%	1.91%	-11.80%	-32.11%
SXS	76 Outperform	£2.02B	8.74	17.33%	4.08%	-11.09%	65.87%
RSW	74 Outperform	£1.91B	19.59	11.07%	2.90%	4.71%	0.43%
DSCV	71 Outperform	£643.84M	26.27	8.07%	1.80%	-5.56%	-27.87%
GHH	70 Outperform	£140.79M	27.19	4.79%	2.22%	1.74%	359.50%
JDG	70 Neutral	£525.16M	50.40	12.29%	1.24%	-1.84%	9.56%
Sector *	62 Neutral	$11.80B	10.31	-7.45%	2.91%	7.43%	-7.78%

Judges Scientific Corporate Events

Judges Scientific Executives Participate in Share Incentive Plan

Judges Scientific plc announced the purchase of ordinary shares by the Trustees of the Share Incentive Plan involving several key executives, including the CEO, CFO, COO, Group Business Development Director, and Group Commercial Director. Each transaction was conducted on the London Stock Exchange, AIM Market, at a price of 7870.0p per share, reflecting the company’s commitment to aligning management interests with shareholder value.

The most recent analyst rating on (GB:JDG) stock is a Buy with a £12230.00 price target. To see the full list of analyst forecasts on Judges Scientific stock, see the GB:JDG Stock Forecast page.

Judges Scientific Allocates Shares to Employees Under Reward Scheme

Judges Scientific announced the acquisition of 28 ordinary shares at a price of 7875p per share, which have been allocated to employees under the company’s reward scheme. This move reflects the company’s ongoing strategy to enhance shareholder value through sustainable profit generation, debt reduction, organic growth, and dividends.

The most recent analyst rating on (GB:JDG) stock is a Buy with a £12230.00 price target. To see the full list of analyst forecasts on Judges Scientific stock, see the GB:JDG Stock Forecast page.

Judges Scientific AGM Resolutions Passed Amid Shareholder Dissent

Judges Scientific announced the successful passing of all resolutions at their recent Annual General Meeting, including the approval of financial statements, remuneration reports, and director re-elections. Notably, over 20% of shareholders opposed the re-election of Ralph Elman as a director, prompting the board to engage with shareholders for feedback. This outcome highlights the company’s commitment to stakeholder engagement and governance, potentially impacting its strategic direction and investor relations.

The most recent analyst rating on (GB:JDG) stock is a Buy with a £10600.00 price target. To see the full list of analyst forecasts on Judges Scientific stock, see the GB:JDG Stock Forecast page.

Judges Scientific Strengthens Employee Incentives with Share Acquisition

Judges Scientific plc announced the acquisition of 655 ordinary shares at a price of 7820p per share, which were immediately allocated to employees as part of the company’s reward scheme. This move reflects the company’s ongoing commitment to rewarding its employees and maintaining a strong operational framework, potentially enhancing its market position and stakeholder confidence.

The most recent analyst rating on (GB:JDG) stock is a Buy with a £12230.00 price target. To see the full list of analyst forecasts on Judges Scientific stock, see the GB:JDG Stock Forecast page.

Judges Scientific Executives Participate in Share Incentive Plan

Judges Scientific plc announced the purchase of ordinary shares by the Trustees of the Share Incentive Plan involving several key executives, including the CEO, CFO, COO, Group Business Development Director, and Group Commercial Director. This transaction, conducted on the London Stock Exchange’s AIM Market, reflects the company’s ongoing commitment to aligning the interests of its management team with those of its shareholders, potentially enhancing stakeholder confidence and reinforcing its market position.

Judges Scientific Announces AGM Details and Annual Report Release

Judges Scientific plc has announced the posting of its Annual Report and Accounts along with the Notice of its Annual General Meeting (AGM), scheduled for May 22, 2025, at The Lansdowne Club in London. Shareholders are encouraged to attend the AGM in person or submit proxy votes online. This announcement underscores the company’s commitment to transparency and shareholder engagement, reflecting its strategic focus on sustainable growth and market presence in the scientific instrument sector.

Judges Scientific Announces Board Changes and New Executive Committee

Judges Scientific has announced a significant change in its board and management structure, with Chief Operating Officer Mark Lavelle planning to retire by September 2026. As part of his transition, Lavelle will step down from the board in May 2025 but will continue to contribute to the group through a newly formed Executive Committee, which will oversee the management of the company. This restructuring aims to enhance the group’s operational and growth capabilities, ensuring continued success and development in the scientific instrument sector.

Judges Scientific Executives Align Interests Through Share Purchases

Judges Scientific plc announced the purchase of ordinary shares by the Trustees of the Share Incentive Plan, involving several key executives including the CEO, CFO, COO, and other directors. This move, conducted on the London Stock Exchange’s AIM Market, reflects a strategic effort to align the interests of the company’s leadership with those of its shareholders, potentially strengthening stakeholder confidence and enhancing the company’s market positioning.

Judges Scientific Director Increases Shareholding

Judges Scientific plc announced that Tim Prestidge, Group Business Development Director, purchased 511 ordinary shares in the company, increasing his holding to 564 shares. This transaction, conducted on the AIM market of the London Stock Exchange, reflects internal confidence in the company’s strategy and potential for growth, potentially impacting stakeholder perceptions positively.

Judges Scientific Confirms 2024 Financial Results

Judges Scientific plc has confirmed its full-year financial results for 2024, with no changes from the preliminary results published in March 2025. The company’s financial statements have been approved by the Board of Directors and audited, reinforcing its stable financial position and ongoing commitment to transparency. This announcement underscores Judges Scientific’s consistent performance and strategic focus on sustainable growth through acquisitions, which is likely to reassure stakeholders of its robust market positioning.

Judges Scientific Navigates Challenging 2024 with Strategic Acquisitions and Dividend Growth

Judges Scientific plc reported a challenging trading year in 2024, with a 2% decrease in revenue and a 20% drop in adjusted operating profit, attributed to delays in a Geotek coring expedition and weaker order intake, particularly in China. Despite these challenges, the company completed three acquisitions and increased its cash conversion to normal levels. The year ended with a proposed final dividend increase of 10%, reflecting the company’s commitment to shareholder returns. Looking forward, Judges Scientific has commenced 2025 with a strong order book and expects performance to align with market expectations, bolstered by strategic acquisitions and a strengthened executive team.